BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$4.89B |
| 2 |
iShares Core MSCI Total International Stock ETF
IXUS
|
+$2.11B |
| 3 |
Cigna
CI
|
+$2.09B |
| 4 |
ExxonMobil
XOM
|
+$1.33B |
| 5 |
Verizon
VZ
|
+$1.32B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$4.73B |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$3.38B |
| 3 |
PX
Praxair Inc
PX
|
+$2.8B |
| 4 |
iShares Russell 1000 ETF
IWB
|
+$2.28B |
| 5 |
iShares Core US Aggregate Bond ETF
AGG
|
+$2.18B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.96% |
| 2 | Healthcare | 14.79% |
| 3 | Financials | 14.43% |
| 4 | Consumer Discretionary | 9.82% |
| 5 | Industrials | 9.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BDSI
3376
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $5.14M | ﹤0.01% |
1,388,297
+189,508
| +16% | +$666K |
|
|
FRTA
3377
DELISTED
Forterra, Inc
FRTA
| $5.13M | ﹤0.01% |
1,365,530
-19,162
| -1% | -$97.5K |
|
3378
CALL
Bank of America
BAC
$446B
| $5.13M | ﹤0.01% |
208,100
+23,700
| +13% | +$643K |
|
3379
Mid Penn Bancorp
MPB
$938M
| $5.12M | ﹤0.01% |
222,286
+9,707
| +5% | +$249K |
|
3380
First Guaranty Bancshares
FGBI
$149M
| $5.09M | ﹤0.01% |
265,203
+10,294
| +4% | +$189K |
|
3381
Gencor Industries
GENC
$233M
| $5.08M | ﹤0.01% |
463,160
+15,233
| +3% | +$174K |
|
|
MXWL
3382
DELISTED
Maxwell Technologies Inc
MXWL
| $5.07M | ﹤0.01% |
2,448,336
+54,636
| +2% | +$148K |
|
|
FRAN
3383
DELISTED
Francesca's Holdings Corporation
FRAN
| $5.07M | ﹤0.01% |
434,816
-6,236
| -1% | -$182K |
|
|
LACQU
3384
DELISTED
Leisure Acquisition Corp. Unit
LACQU
| $5.07M | ﹤0.01% |
500,000
| – | – |
|
|
AXNX
3385
DELISTED
Axonics, Inc. Common Stock
AXNX
| $5.01M | ﹤0.01% |
+331,870
| New | +$4.94M |
|
3386
Liquidia Corp
LQDA
$7.97B
| $5.01M | ﹤0.01% |
231,400
+15,415
| +7% | +$360K |
|
3387
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$67.6B
| $5.01M | ﹤0.01% |
60,447
+2,842
| +5% | +$234K |
|
3388
Global Water Resources
GWRS
$213M
| $5M | ﹤0.01% |
492,978
+1,836
| +0.4% | +$19.2K |
|
3389
Hallador Energy
HNRG
$732M
| $4.97M | ﹤0.01% |
981,318
+25,988
| +3% | +$152K |
|
3390
Vanguard World Funds Extended Duration ETF
EDV
$3.47B
| $4.95M | ﹤0.01% |
43,619
+43,534
| +51,216% | +$4.64M |
|
|
ADAP
3391
DELISTED
Adaptimmune Therapeutics
ADAP
| $4.92M | ﹤0.01% |
856,415
+81,010
| +10% | +$598K |
|
|
VSA
3392
VisionSys AI
VSA
$9.72M
| $4.87M | ﹤0.01% |
309
+25
| +9% | +$480K |
|
3393
PUT
Bausch Health
BHC
$2.44B
| $4.86M | ﹤0.01% |
263,000
+40,500
| +18% | +$963K |
|
|
ODT
3394
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $4.84M | ﹤0.01% |
344,069
+5,244
| +2% | +$81.7K |
|
3395
Hercules Capital
HTGC
$3.19B
| $4.83M | ﹤0.01% |
436,700
-23,000
| -5% | -$280K |
|
3396
iShares MSCI Switzerland ETF
EWL
$2.25B
| $4.79M | ﹤0.01% |
151,932
-2,630
| -2% | -$85.9K |
|
|
PVBC
3397
DELISTED
Provident Bancorp
PVBC
| $4.78M | ﹤0.01% |
445,503
+14,543
| +3% | +$182K |
|
3398
Chunghwa Telecom
CHT
$32.8B
| $4.77M | ﹤0.01% |
133,240
-30,458
| -19% | -$1.06M |
|
|
EIGR
3399
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $4.76M | ﹤0.01% |
15,623
+8,135
| +109% | +$2.63M |
|
3400
Safe Bulkers
SB
$765M
| $4.75M | ﹤0.01% |
2,667,754
+69,107
| +3% | +$156K |
|
Similar funds
BlackRock's Q4 2018 Portfolio in Review
As of Q4 2018, BlackRock held 5,211 positions worth $1.98T, down 14% from $2.31T the previous quarter. Its ten largest holdings account for 14% of the portfolio.
BlackRock's Q4 2018 filing shows 169 new, 3,017 increased, 1,308 reduced and 195 closed positions. Its largest new stake was Linde: 30,937,347 shares worth $4.83B. The largest sale was Aetna Inc, an estimated $4.73B.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q4 2018 buy was Linde: 30,937,347 shares worth $4.83B.
- BlackRock added most to iShares Core MSCI Total International Stock ETF in Q4 2018, an estimated $2.11B increase.
- BlackRock's biggest Q4 2018 reduction was iShares Russell 1000 ETF, cutting an estimated $2.28B.
- BlackRock fully exited Aetna Inc in Q4 2018, selling an estimated $4.73B.
- BlackRock's ten largest holdings make up 14% of its $1.98T portfolio in Q4 2018.
- BlackRock opened 169 new positions and closed 195 in Q4 2018.
- BlackRock's portfolio value fell 14% quarter-over-quarter to $1.98T.
Based on BlackRock's 13F filing for Q4 2018, filed 8 Feb 2019.